Trump on Thursday signed an executive order that set new tariffs on a wide swath of U.S. trading partners to go into effect ...

UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...

U.S. trade partners reacted Friday to President Donald Trump's executive order now set to introduce new tariffs on many of ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called ...

Post-operative nausea and vomiting (PONV) market to rise from $2.11B in 2024 to $2.97B in 2029, driven by innovations in ...

The global injectable drug delivery market is experiencing a significant transformation, poised to reach a staggering USD 113 ...

The second quarter of 2025 got off to a rocky start, as higher-than-expected U.S. tariff announcements weighed heavily on ...

BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”) today announced the appointment of Kristin Yarema, Ph ...

The exanthema market is projected to grow from USD 1.39 billion in 2024 to USD 2.51 billion by 2034 at a CAGR of 6.10%. This growth is driven by risi ...

The Global Regenerative Medicine Market, valued at approximately USD 34.56 billion in 2023, is projected to witness an exponential surge, growing at a compound annual growth rate ...

The melanoma market is predicted to surge during the forecast period (2025–2034) owing to factors, as the increasing incidence of melanoma, the launc ...